This inventor holds 1 USPTO granted patent. Top assignee: Nanjing Nuoyuan Medical Devices Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zihan Wu and a Novel Tumor-Imaging Probe.
Introduction
Zihan Wu is an inventor based in Nanjing, China. His patent work includes a proposed technetium-99m-labeled probe for imaging tumors by targeting fibroblast activation protein (FAP).
Latest Patents
Wu is associated with 1 patent: “Brand-new skeleton 99MTC-FAPI diagnostic probe and use thereof in preparation of drug or reagent for diagnosing tumors.” The disclosure describes a dimeric compound targeting FAP and its use in preparing a drug or reagent for tumor diagnosis. It reports that, compared with conventional FAP-inhibitor radiopharmaceuticals, the technetium-99m-labeled compound has high tumor uptake, strong contrast between tumor and background, and favorable biodistribution in vivo.
Career Highlights
Wu is associated with Nanjing Nuoyuan Medical Devices Co., Ltd. The patent reflects work on radiopharmaceutical probe design and potential diagnostic applications in tumor imaging.
Collaborations
The patent information names Yueqing Gu and Yang Luo as Wu’s coworkers.
Conclusion
Zihan Wu’s disclosed patent centers on a technetium-99m-labeled FAP-targeting dimeric probe intended to support tumor diagnosis, with reported imaging and biodistribution advantages.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile